These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36929215)

  • 41. Down-regulation of Sphk2 suppresses bladder cancer progression.
    Sun E; Zhang W; Wang L; Wang A; Ma C; Lei M; Zhou X; Sun Y; Lu B; Liu L; Han R
    Tumour Biol; 2016 Jan; 37(1):473-8. PubMed ID: 26224479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co-Delivery of Paclitaxel and shMCL-1 by Folic Acid-Modified Nonviral Vector to Overcome Cancer Chemotherapy Resistance.
    Nie W; Wang B; Mi X; Chen J; Yu T; Miao J; Lin Y; Yang T; Ran M; Hong Z; Liu X; Liang X; Qian Z; Gao X
    Small Methods; 2021 May; 5(5):e2001132. PubMed ID: 34928100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RNAi-induced K-Ras gene silencing suppresses growth of EC9706 cells and enhances chemotherapy sensitivity of esophageal cancer.
    Wang XJ; Zheng YL; Fan QX; Zhang XD
    Asian Pac J Cancer Prev; 2012; 13(12):6517-21. PubMed ID: 23464485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect and mechanism of siRNA targeting α-enolase gene combined with paclitaxel on proliferation, invasion and apoptosis of hepatocellular carcinoma cell].
    Cui H; Gao QQ; Zhuang H; He T; Wan BS; Wang XQ; Zhang L; Huang T; Han F
    Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1241-1247. PubMed ID: 34915631
    [No Abstract]   [Full Text] [Related]  

  • 46. Proliferation inhibition and apoptosis promotion by dual silencing of VEGF and Survivin in human osteosarcoma.
    Gu J; Ji Z; Li D; Dong Q
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):59-67. PubMed ID: 30566604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells.
    Hsiao PW; Chang CC; Liu HF; Tsai CM; Chiu TH; Chao JI
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):97-104. PubMed ID: 17540426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
    Kar R; Palanichamy JK; Banerjee A; Chattopadhyay P; Jain SK; Singh N
    Clin Transl Oncol; 2015 Sep; 17(9):737-42. PubMed ID: 26033427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
    Le XF; Mao W; He G; Claret FX; Xia W; Ahmed AA; Hung MC; Siddik ZH; Bast RC
    J Natl Cancer Inst; 2011 Sep; 103(18):1403-22. PubMed ID: 21813412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis.
    Okada T; Ding G; Sonoda H; Kajimoto T; Haga Y; Khosrowbeygi A; Gao S; Miwa N; Jahangeer S; Nakamura S
    J Biol Chem; 2005 Oct; 280(43):36318-25. PubMed ID: 16103110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.
    Zhang G; Zheng H; Zhang G; Cheng R; Lu C; Guo Y; Zhao G
    Cancer Cell Int; 2017; 17():46. PubMed ID: 28428733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells.
    Miao GY; Lu QM; Zhang XL
    World J Gastroenterol; 2007 Feb; 13(8):1170-4. PubMed ID: 17451195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Knockdown of SIRT1 inhibits proliferation and promotes apoptosis of paclitaxel-resistant human cervical cancer cells.
    Xia X; Zhou X
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):36-41. PubMed ID: 29808798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [siRNA targeted against survivin induces apoptosis of pancreatic cancer cells].
    Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):169-73. PubMed ID: 16503521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
    Chen X; Zhang Y; Tang C; Tian C; Sun Q; Su Z; Xue L; Yin Y; Ju C; Zhang C
    Int J Pharm; 2017 Aug; 529(1-2):102-115. PubMed ID: 28642204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer.
    Li W; Cao Y; Xu J; Wang Y; Li W; Wang Q; Hu Z; Hao Y; Hu L; Sun Y; Xu G; Ao G
    J Exp Clin Cancer Res; 2017 Oct; 36(1):144. PubMed ID: 29037225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma.
    Sun X; Chen Y; Zhao H; Qiao G; Liu M; Zhang C; Cui D; Ma L
    Drug Deliv; 2018 Nov; 25(1):1718-1727. PubMed ID: 30269613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.
    Wang J; Lu Z; Yeung BZ; Wientjes MG; Cole DJ; Au JL
    J Control Release; 2014 Mar; 178():79-85. PubMed ID: 24462901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
    Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.
    Liu WS; Yan HJ; Qin RY; Tian R; Wang M; Jiang JX; Shen M; Shi CJ
    Dig Dis Sci; 2009 Jan; 54(1):89-96. PubMed ID: 18594980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.